热门资讯> 正文

Regenxbio提交3亿美元混合货架产品

2025-11-27 06:34

REGENXBIO, Inc.(RGNX) 0

Regenxbio (RGNX) has filed a shelf registration to offer up to $300M in securities.
The offering may include common stock, preferred stock, debt securities, warrants, rights, or units, in one or more combinations and tranches.

More on Regenxbio

REGENXBIO's Late-Stage Pipeline Momentum Strengthens After Q3 Earnings Beat
REGENXBIO Inc. (RGNX) Q3 2025 Earnings Call Transcript
Regenxbio: Poised For Breakthrough With RGX-121 Gene Therapy In Hunter Syndrome
REGENXBIO plans top-line RGX-202 Duchenne data release in early Q2 2026 while advancing toward 2027 commercial launch
Regenxbio Q3 2025 Earnings Preview

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。